HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2025)

HUTCHMED (China)'s (HCM) quarterly Other Non-Current Assets came in at $10.3 million in Q4 2025, up 114.65% year-on-year from $4.8 million in Q4 2024, and down 74.59% on a QoQ basis from $40.6 million in Q2 2025.

HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 11 years of Other Non-Current Assets data on file, last reported at $10.3 million in Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 114.65% year-over-year to $10.3 million in Q4 2025; TTM through Dec 2025 was $10.3 million, a 114.65% increase from a year earlier, with the FY2025 full-year figure at $20.1 million, up 61.47% from the prior year.
  • Other Non-Current Assets for Q4 2025 stood at $10.3 million, down from $40.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for HCM reached as high as $4.5 billion in Q4 2023 and fell as low as $4.8 million in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $426.6 million across 5 years, with a median of $27.0 million in 2021.
  • Across the five-year window, Other Non-Current Assets surged 87351.98% in 2023 and tumbled 99.89% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $5.5 million in 2021, then slipped by 7.39% to $5.1 million in 2022, then jumped by 87351.98% to $4.5 billion in 2023, then tumbled by 99.89% to $4.8 million in 2024, then soared by 114.65% to $10.3 million in 2025.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $10.3 million in Q4 2025, $40.6 million in Q2 2025, and $4.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - 10.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.32 Mn
Jun 30, 2025 40.62 Mn
Dec 31, 2024 4.81 Mn
Jun 30, 2024 37.27 Mn
Dec 31, 2023 4.45 Bn
Jun 30, 2023 39.55 Mn
Dec 31, 2022 5.09 Mn
Jun 30, 2022 45.04 Mn
Dec 31, 2021 5.50 Mn
Jun 30, 2021 24.71 Mn
Mar 31, 2021 26.97 Mn
Dec 31, 2020 20.17 Mn
Jun 30, 2020 6.64 Mn
Dec 31, 2019 253,000.00
Sep 30, 2019 6.58 Mn
Jun 30, 2019 6.77 Mn
Mar 31, 2019 6.77 Mn
Dec 31, 2018 292,000.00
Jun 30, 2018 6.58 Mn
Dec 31, 2017 1.65 Mn